Lind Kevin Robert — SEC Form 4 filings
SEC reporting owner CIK 1677036. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-03.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-09 to 2026-08-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Longboard Pharmaceuticals, Inc. (LBPH) | President and CEO, Director | 5 | — | — | 15 |
| Apnimed, Inc. (APMD) | Chief Executive Officer, Director | 1 | — | — | 7 |
| Avalo Therapeutics, Inc. (AVTX) | Director | 5 | — | — | 5 |
Form 4 filings — Lind Kevin Robert
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | Apnimed, Inc. (APMD) | Disposition to issuer (D): 74,128 (derivative) @ $0 · Grant/award (A): 74,128 (derivative) @ $0 · Disposition to issuer (D): 1,186,278 (derivative) @ $0 · Grant/award (A): 1,186,278 (derivative) @ $0 · Grant/award (A): 108,916 (derivative) @ $0 · Disposition to issuer (D): 108,916 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-02 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,105 (derivative) @ $15.04 | EDGAR |
| 2026-06-04 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 20,100 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 1,370 (derivative) @ $12.13 | EDGAR |
| 2026-01-05 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 848 (derivative) @ $14.74 | EDGAR |
| 2025-10-02 | 4 | Avalo Therapeutics, Inc. (AVTX) | Grant/award (A): 40,200 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Code (U): 363,740 @ $60 · Disposition to issuer (D): 255,377 (derivative) · Disposition to issuer (D): 192,783 (derivative) · Disposition to issuer (D): 325,850 (derivative) · Disposition to issuer (D): 332,134 (derivative) · Disposition to issuer (D): 22,000 (derivative) | EDGAR |
| 2024-11-13 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Option exercise (M): 12,808 @ $3.12 · Gift (G): 80,000 @ $0 · Option exercise (M): 12,808 (derivative) @ $0 | EDGAR |
| 2024-10-29 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Option exercise (M): 80,265 @ $3.12 · Option exercise (M): 2,217 @ $4.20 · Option exercise (M): 80,265 (derivative) @ $0 · Option exercise (M): 2,217 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 332,134 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1677036 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →